TROP2 Membrane Localization Predicts Dato DXd Outcome

Source-gap reconciliation: a peer-reviewed Nature Medicine paper appeared online November 11 and proposes a computational TROP2 normalized membrane ratio as a predictive biomarker for datopotamab deruxtecan in nonsquamous NSCLC without actionable alterations.




